Q-omics provides the consensus-scored SNORD116-20 profile across patient tissues and cancer cell-line models. Additionally, SNORD116-20 RNA expression shows 1 significant drug associations, with the highest sampling consensus in PEMB_ALL.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SNORD116-20 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SNORD116-20 in patient tissues and cancer cell lines. In patient samples, SNORD116-20 shows the broadest associations at the RNA and protein expression levels, with PEMB_ALL recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Drug	1	PEMB_ALL (1)	view →